Tharimmune announces upcoming conference presentations

Bridgewater, nj / accesswire / october 25, 2024 / tharimmune, inc. (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announces that management will be participating in two upcoming conferences. nir barak, m.d.
THAR Ratings Summary
THAR Quant Ranking